CogState Ltd
ASX:CGS

Watchlist Manager
CogState Ltd Logo
CogState Ltd
ASX:CGS
Watchlist
Price: 1.827 AUD -0.71% Market Closed
Market Cap: 308.6m AUD

Net Margin
CogState Ltd

15.6%
Current
14%
Average
1.8%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
15.6%
=
Net Income
7.3m
/
Revenue
47.2m

Net Margin Across Competitors

CogState Ltd
Glance View

Market Cap
314.1m AUD
Industry
Health Care

Cogstate Ltd. is a global cognitive science company. The firm provides computerized cognitive tests across various domains and support electronic clinical outcome assessment (eCOA) solutions. The firm's segment includes Clinical trials, Healthcare and Research. In the Clinical trials segment, the Company's technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians to assess cognitive decline. Research segment offers various research studies and academic collaborations across various indication of diseases.

CGS Intrinsic Value
1.686 AUD
Overvaluation 8%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
15.6%
=
Net Income
7.3m
/
Revenue
47.2m
What is the Net Margin of CogState Ltd?

Based on CogState Ltd's most recent financial statements, the company has Net Margin of 15.6%.

Back to Top